Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMpac Group Plc Regulatory News (MPAC)

Share Price Information for Mpac Group Plc (MPAC)

Share Price is delayed by 15 minutes
Get Live Data
210.00    -2.50 (-1.18%)
Bid:
205.00
Ask:
215.00
Spread: 10.00 (4.878%)
Market Cap: £63.15m
MPAC Live PriceLast checked at - London Stock Exchange

Intraday Mpac Group Plc Share Chart

Full Year Trading update

16 Jan 2025 07:00

RNS Number : 4994T
Mpac Group PLC
16 January 2025
 

16 January 2025

AIM: MPAC

 

Mpac Group plc

(''Mpac'', "Company" or "Group")

 

Full Year Trading update

 

FY24 trading performance in line with market expectations, a healthy opening order book for 2025 and good initial progress made on integrating H2 24 acquisitions

 

 

Mpac Group plc, a global leader in high-speed packaging and automation solutions, today announces a trading update (unaudited) for the year ended 31 December 2024 ("FY24").

 

The Board is pleased with the Group's FY24 performance and expects that it will report underlying profit before tax in line with market expectations of £10.5m (FY23: £7.1m). As anticipated, profit before tax in H2 24 was substantially above H1 24, aided by improving project margins and operational efficiencies.

 

The Group successfully executed the acquisitions of BCA Automation and CSi Palletising in H2 24 (the "Acquisitions"). The Acquisitions have continued to perform in line with the Board's expectations. The integration is progressing well and according to plan.

 

After the completion of the Acquisitions, the Group closes FY24 with net debt of £37.0m (FY23: net cash £2.1m) and a reduction in working capital to £7.0m (FY23: £13.2m), which includes circa £8.0m of invoiced receivables, due in 2024, most of which has been received in early January 2025. The Group remains on track to bring net debt down to less than 1 times EBITDA by the end of 2025.

 

Quote activity and the prospect pipeline within the growth sectors in which Mpac operates of Healthcare and Food and Beverage continues to be strong and following the Acquisitions, the Group ended FY24 with an increased value of the closing order book at c.£111.0m (FY23: £72.5m) providing good coverage over 2025 forecast revenue. 

 

With an increasingly diverse prospect pipeline and order book and good quote activity, as well as a stronger offering through combined product lines from our existing and acquired businesses, the Group is well placed to deliver on market expectations for the current financial year and beyond. The Board remains confident that the Group will continue progressing its long-term growth strategy.

 

Adam Holland, Chief Executive, commented:

 

We are pleased with full year 2024 financial performance, which is in line with market expectations. 2024 has proved to be a transformational year for the Group, with the acquisitions of CSi, BCA and Siga Vision providing the platform for a step change in scale and profitability, accelerating our progress towards our strategic objectives. The acquisitions materially diversify the Group's portfolio enabling the Group to provide a fuller line offering, as well as access to new customer relationships providing a platform for continued robust organic growth.

 

We would like to thank shareholders for their support of the acquisition of CSi and their ongoing support as we head into 2025. We anticipate reporting for 2024 record levels of revenue, with underlying profit before tax breaking through the £10m mark for the first time. We start 2025 with a larger and more diverse order book from our resilient end markets providing a high level of coverage over forecast revenue, supporting delivery of our expectations for further growth in the year ahead.''

 

The Group's full year results for the year ended 31 December 2024 are expected to be announced in the week commencing 28 April 2025, allowing for the additional time required to complete the first audit of the enlarged Group following the recent significant acquisitions.

 

 

For further information, please contact:

Mpac Group plc

Adam Holland, Chief Executive

Will Wilkins, Chief Financial Officer

Tel: +44(0)24 7642 1100

Shore Capital (Nominated Adviser & Broker)

Advisory

Patrick Castle

Sophie Collins

Broking

Henry Willcocks

 

 

Tel: +44(0)20 7408 4050

 

Panmure Liberum (Joint Broker)

Edward Mansfield

Will King

Anake Singh

 

Hudson Sandler (Financial PR)

Nick Lyon

Nick Moore

Francesca Rosser

Tel: +44 (0) 20 3100 2000

 

 

 

 

Tel: +44 (0) 20 7796 4133

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTGPUCCGUPAGMA
Date   Source Headline
25th Apr 20135:13 pmRNSResult of AGM
2nd Apr 20133:31 pmRNSHolding(s) in Company
8th Mar 20133:48 pmRNSDirector/PDMR Shareholding
27th Feb 20135:07 pmRNSDirector/PDMR Shareholding
27th Feb 20137:00 amRNSFinal Results
7th Feb 20137:00 amRNSNotice of Results
25th Oct 20127:00 amRNSInterim Management Statement
20th Sep 201211:56 amRNSDirector Declaration
31st Aug 20127:00 amRNSHalf Yearly Report
17th Aug 20121:00 pmRNSNotification of Half-Year Results
26th Apr 20124:02 pmRNSResult of AGM
26th Apr 201212:31 pmRNSInterim Management Statement
6th Mar 20124:21 pmRNSDirector/PDMR Shareholding
6th Mar 20124:16 pmRNSDirector/PDMR Shareholding
28th Feb 20123:46 pmRNSDirector/PDMR Shareholding
28th Feb 20123:42 pmRNSDirector/PDMR Shareholding
28th Feb 20127:00 amRNS2011 Preliminary Results
8th Feb 20127:00 amRNSNotification of Preliminary Announcement
31st Jan 20126:01 pmRNSHolding(s) in Company
12th Jan 20121:12 pmRNSHolding(s) in Company
7th Dec 201111:35 amRNSDirector Declaration
24th Oct 20117:00 amRNSInterim Management Statement
25th Aug 20117:00 amRNS2011 Half-year Announcement
11th Aug 20117:00 amRNSNotification of Half-Year Results
9th May 20111:44 pmRNSResult of AGM
6th May 20112:05 pmRNSInterim Management Statement
2nd Mar 20112:48 pmRNSDirector/PDMR Shareholding
2nd Mar 20112:47 pmRNSDirector/PDMR Shareholding
1st Mar 20117:02 amRNSChange of Adviser
1st Mar 20117:01 amRNSBoard Changes
1st Mar 20117:00 amRNS2010 Preliminary Announcement
23rd Feb 201112:05 pmRNSNotification of Preliminary Announcement
27th Jan 201111:53 amRNSDirectorate Change
22nd Dec 20109:04 amRNSPre-Close Trading Update
25th Oct 20108:39 amRNSDirectorate Change
25th Oct 20108:39 amRNSDirectorate Change
25th Oct 20108:33 amRNSInterim Management Statement
25th Oct 20108:33 amRNSInterim Management Statement
27th Aug 20107:01 amRNSChange of Adviser
27th Aug 20107:00 amRNS2010 Half-year Announcement
19th Aug 20107:00 amRNSNotification of Half-Year Results
13th Aug 20104:31 pmRNSHolding(s) in Company
9th Aug 20104:54 pmRNSHolding(s) in Company
15th Jul 201011:07 amRNSHolding(s) in Company
24th Jun 201010:36 amRNSHolding(s) in Company
22nd Jun 20107:00 amRNSInterim Management Statement
6th May 20109:45 amRNSDirector/PDMR Shareholding
4th May 20109:45 amRNSDoc re. Annual General Meeting
30th Apr 20102:38 pmRNSInterim Management Statement
25th Mar 20105:37 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.